◆ 会议时间：2024年9月27日至10月1日
◆ 会议地点：美国 费城

◆ 会议简介：

2024年国际帕金森病与运动障碍大会将于2024年9月27日至10月1日在美国费城举行，会议由国际帕金森病与运动障碍学会(MDS)主办。每年的帕金森病和运动障碍国际大会都会吸引数千名对当前运动障碍诊断和治疗的研究/方法感兴趣的临床医生、研究人员、学员和行业支持者。MDS国际会议的目的是促进交流、分享经验，并推动相关临床和科学学科的发展。MDS2023：5200+与会者，1,858篇摘要；220位世界顶尖专家。

国际帕金森与运动障碍学会(MDS)是一个由对帕金森病、相关的神经退行性疾病和神经发育障碍，多动性运动障碍和肌张力和运动控制异常等领域宣感兴趣的临床医生、科学家和其他医疗保健专业人士组成的非营利组织。MDS的宗旨是促进与运动障碍相关的神经科学的发展；提高患者的诊治水平；鼓励研究；出版医学期刊，组织与赞助科学研讨会和国际会议；分享想法并促进相关临床和科学学科的发展；为临床医生、科学家和公众提供教育计划，旨在提高与运动障碍相关的科学和临床知识；等等。未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com).

International Congress of Parkinson's Disease and Movement Disorders (MDS 2024)

时间/Date: September 27 - October 1, 2024
地点/Venue: Pennsylvania Convention Center, Philadelphia, PA, USA

Organised by：International Parkinson and Movement Disorder Society (MDS)

摘要征文投稿：

2024 Abstract Submissions Deadline: March 15, 2024

点此提交摘要>>>Submit Abstract>>>

Format

Text limit of 2,500 characters (including spaces) for the body of the abstract. The size limit includes characters and spaces in the Abstract Title and Abstract Body. Please note that spaces are included in the overall character count. The size limit does not include author information or reference sections.

All abstract submissions must be written and presented in English.

Abstracts should be arranged as follows:

• Objective
• Background
• Methods
• Results
• Conclusions

*You may submit a case report using the standard abstract format

When compiling your submission please note the following:

• Do not include any identifying information directly on the abstract.
• Do not include branded product names in the abstract. If the abstract is found to contain marketing, rather than scientific content, the abstract will be rejected.
• Only nonproprietary (generic) drug names should be used and should be written without capitals.
• Select one (1) category under which the abstract should be reviewed. If the abstract covers more than one topic, please choose the most appropriate category.
  • If it is determined that the abstract should be re-categorized, MDS will ensure that the new category placement is in the best interest of the work and easily searchable by International Congress attendees as well as online researchers.
• The use of standard abbreviations is desirable. A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word for which it stands.

Submission and Eligibility

Abstract submission deadline: March 15, 2024

All submitted abstracts become the property of MDS.

All accepted abstracts are published by MDS.

An individual may be the first author on a maximum of three (3) abstracts.

An individual may be a contributing author on an unlimited number of abstracts.

MDS Members and non-members are welcome to submit abstracts.

There is no fee to submit an abstract.

*If your abstract includes a rating scale or other resources, please make sure permission has been granted and all applicable fees have been paid.

Abstract presenters are encouraged to attend the International Congress to present their abstract in person. In-person abstract presenters are required to register for the International Congress and pay applicable registration fees.

Abstracts must be submitted in their final form on March 15, 2024. Requests to edit abstract data and/or outcomes after the submission deadline will not be granted. All other abstract edits are not guaranteed.

Presentation Formats

The 2024 International Congress will take place in Philadelphia, PA, and will feature in-person printed poster presentations for all accepted abstracts.

• Accepted abstract presenters should plan to attend the Congress in full to present their printed poster during the scheduled poster session(s).
• Please plan to attend from September 27 – October 1, in case of any schedule changes

Publication

All accepted abstracts will be published in an e-supplement to the Movement Disorders journal online edition. All submitted abstracts become the property of MDS.

All accepted abstracts will be published on September 27, 2024, and available for viewing on the MDS Congress platform.

Accepted MDS abstracts are embargoed until 8:00 am EST (local Philadelphia time) on September 27, 2024.

Previously Published Abstracts & Plagiarism

MDS only accepts original work. By submitting your abstract, you affirm that your abstract is your own, either individually or as a group. Should plagiarism be detected, the abstract will be rejected.

Abstracts that have been presented at other meetings may be submitted if they have not been previously published. Submitted abstracts that have been presented at other meetings must include the previous meeting name and presentation date cited accordingly in the abstract body, after the Conclusion.

Abstracts that have been previously published will not be accepted by MDS.

If the abstract submission is scheduled for publication after the submission deadline but prior to the MDS publication date, September 27, 2024, then the abstract must be withdrawn.

MDS does not accept abstracts that have been previously published by MDS (encore abstracts).

If the abstract is found to have been previously published in another MDS publication or a previous edition of the Movement Disorders journal, the designated contact person will be notified and the abstract will be rejected.

All abstracts presented at a previous MDS International Congress or MDS Regional Congress (PAS Congress or AOPMC) have been published by MDS.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。